for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

KANEKA CORPORATION

4118.T

Latest Trade

3,525.00JPY

Change

5.00(+0.14%)

Volume

224,200

Today's Range

3,500.00

 - 

3,555.00

52 Week Range

3,030.00

 - 

4,535.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
3,520.00
Open
3,505.00
Volume
224,200
3M AVG Volume
7.88
Today's High
3,555.00
Today's Low
3,500.00
52 Week High
4,535.00
52 Week Low
3,030.00
Shares Out (MIL)
65.23
Market Cap (MIL)
239,360.00
Forward P/E
12.52
Dividend (Yield %)
2.70

Next Event

Q3 2020 Kaneka Corp Earnings Release

Latest Developments

More

Kaneka To Hold 86.61% In Ab-Biotics

Kaneka To Hold 66.33% Of Ab-Biotics

Kaneka Makes Voluntary Public Offer Of Acquisition For AB-Biotics

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About KANEKA CORPORATION

KANEKA CORPORATION is a Japan-based company engaged in four business segments. The Material Solutions Unit segment includes general purpose vinyl chloride resin, caustic soda, polyvinyl chloride special resin, modifier, modified silicone polymer, biodegradable polymer. Quality of Life Solutions Unit segment includes expanded styrene resin and molded products, extruded polystyrene foam boards, bead method expanded polyolefin, solar circuit method, super heat resistant polyimide films, optical materials, super heat conductive graphite sheets, solar cells, storage batteries for housing and others. The Health Care Solutions Unit segment includes medical devices, low molecular weight pharmaceutical raw materials, biopharmaceuticals, etc. The Nutrition Solutions Unit segment includes functional food ingredients, margarine, shortening, baker's yeast, spices, antifreeze ingredients, functional fertilizers and feeds.

Industry

Chemical Manufacturing

Contact Info

Nakanoshima Festival Tower

2-3-18, Nakanoshima, Kita-ku

+81.6.62265050

http://www.kaneka.co.jp

Executive Leadership

Kimikazu Sugawara

Chairman of the Board, Representative Director

Mamoru Kadokura

President, Representative Director

Minoru Tanaka

Vice President, Representative Director

Shinobu Ishihara

Senior Managing Executive Officer, Director

Shinichiro Kametaka

Senior Managing Executive Officer, Director

Key Stats

2.80 mean rating - 5 analysts
Sell
Hold
Buy
Revenue (MM, JPY)

2017

0.5K

2018

0.6K

2019

0.6K

2020(E)

0.6K
EPS (JPY)

2017

308.600

2018

328.450

2019

339.150

2020(E)

281.117
Price To Earnings (TTM)
13.11
Price To Sales (TTM)
0.39
Price To Book (MRQ)
0.69
Price To Cash Flow (TTM)
4.62
Total Debt To Equity (MRQ)
36.94
LT Debt To Equity (MRQ)
14.92
Return on Investment (TTM)
4.50
Return on Equity (TTM)
2.95

Latest News

Latest News

BRIEF-Kaneka To Hold 86.61% In Ab-Biotics

* SAID ON THURSDAY, THE OFFER BY KANEKA EUROPE, UNIT OF KANEKA , FOR SHARES OF AB-BIOTICS WAS ACCEPTED BY ADDITIONAL 18.21% OF SHARE CAPITAL

BRIEF-Kaneka To Hold 66.33% Of Ab-Biotics

* SAID ON FRIDAY, THE BID BY KANEKA EUROPE HOLDING COMPANY NV, UNIT OF KANEKA CORP, WAS ACCEPTED BY 26.57% OF THE CAPITAL TO WHICH THE BID WAS DIRECTED

BRIEF-Kaneka Makes Voluntary Public Offer Of Acquisition For AB-Biotics

* SAID ON TUESDAY, KANEKA EUROPE HOLDING COMPANY HAS MADE A VOLUNTARY PUBLIC OFFER OF ACQUISITION OF ALL SHARES OF AB-BIOTICS IT DOES NOT OWN

BRIEF-AB-Biotics Enters Into License Agreement With Kaneka Americas Holding

* SAYS ENTERS INTO LICENSE AGREEMENT WITH US COMPANY KANEKA AMERICAS HOLDING

BRIEF-Kaneka wins lawsuit regarding patent infringement in US

* Says the co won the lawsuit against Zhejiang Medicine Co. Ltd and ZMC-USA, LLC.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up